We have licensed exclusive worldwide IP rights for AMD101 topical ophthalmic products from AMD Therapeutics LLC and its co-development partners. These rights will remain in effect for approximately 20 years.
We have licensed exclusive worldwide IP rights for AMD101 topical ophthalmic products from AMD Therapeutics LLC and its co-development partners. These rights will remain in effect for approximately 20 years.